Added to YB: 2026-07-06
Pitch date: 2026-07-01
CAI [neutral]
Caris Life Sciences, Inc.
-6.31%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
Market Cap
$5.2B
Pitch Price
$19.01
Price Target
N/A
Dividend
N/A
EV/EBITDA
34.22
P/E
-10.18
EV/Sales
5.27
Sector
Biotechnology
Category
growth
Show full summary:
Szew Invest | Q2 2026 Update - Caris Life Sciences, Inc.
CAI (holding update): Techbio/diagnostics play in cancer detection via blood samples—predicts tumor presence, location & optimal therapy. Well-positioned across categories & attractively valued vs peers, hence only diagnostic stock held & given higher weighting.
Read full article (1 min)